<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04156048</url>
  </required_header>
  <id_info>
    <org_study_id>12-4970-BO B</org_study_id>
    <nct_id>NCT04156048</nct_id>
  </id_info>
  <brief_title>HIV&amp;HEART Aging Study (12,5 Year Follow up)</brief_title>
  <acronym>HIV&amp;HEART</acronym>
  <official_title>A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk, New Cardiovascular Events and the Cardiovascular Diseases in HIV-infected Patients: 12,5 Year Follow up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The HIV/HEART Aging study (HIVH) is an ongoing, prospective, multicentre trial that was
      conducted to assess the incidence, the prevalence and the clinical course of cardiovascular
      diseases (CVD) in HIV-infected patients. The study population includes outpatients from
      specialized HIV-care units of the German Ruhr region, who were at least 18 years of age, were
      known to have a HIV-infection and exhibited a stable disease status within 4 weeks before
      inclusion into the trial. From March 2004 (Pilot phase) to October 2019 (12,5 year Follow-up)
      1806 HIV+ patients were recruited in a consecutive manner. The standardised examinations
      included a targeted assessment of medical history and physical examination. Blood was drawn
      for comprehensive laboratory tests including HIV specific parameters (CD4 cell count, HIV-1
      RNA levels) and cardiovascular items (lipid concentrations, BNP values and renal parameters).
      Furthermore, non-invasive tests were performed during the initial visit, including additional
      heart rate and blood pressure measurements, electrocardiogram (ECGs) and transthoracic
      echocardiography (TTE). Examinations were completed in accordance with previously defined
      standard operating procedures. CVD were defined as coronary, cerebrovascular, peripheral
      arterial disease, heart failure or cardiac vitium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A comprehensive detailed description of the study procedures had been previously published
      (European Journal of medical research 2007;12:243-248).

      Comprehensive non invasive cardiovascular examination

        -  Anamnesis

        -  File recherche,Physical examination

        -  Documentation of the cardiovascular and antiretroviral medical therapy

        -  Electrocardiogram

        -  Transthoracic echocardiography

        -  Exercise electrocardiogram

        -  Exercise Montreal Cognitive Assessment test

        -  Exercise the Grooved Pegboard test

        -  Blood collection

        -  Questionnaire to quality of life and health economics
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 3, 2017</start_date>
  <completion_date type="Actual">November 6, 2019</completion_date>
  <primary_completion_date type="Actual">October 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular Diseases in HIV-infected Patients</measure>
    <time_frame>Baseline up to 12,5 year follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of classic cardiovascular risk factors of coronary artery disease, comorbidities and antiretroviral therapy</measure>
    <time_frame>Baseline up to 12,5 year follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of new HIV-specific risk factors of coronary artery disease, comorbidities and antiretroviral therapy</measure>
    <time_frame>Baseline up to 12,5 year follow up</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">1809</enrollment>
  <condition>HIV Infections</condition>
  <condition>Coronary Disease</condition>
  <condition>Myocardial Infarction</condition>
  <condition>HIV Encephalopathy</condition>
  <condition>Aging</condition>
  <condition>Heart Failure</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      stored blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        population affected by HIV
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Known HIV-infection

          -  Signed informed consent

        Exclusion Criteria:

          -  Acute cardiovascular disease

          -  Unstable hemodynamic status in the three weeks before inclusion

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Esser, PD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Departement of dermatology and venerology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut für Medizinische Informatik, Biometrie und Epidemiologie</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen, Klinik für Dermatologie</name>
      <address>
        <city>Essen</city>
        <state>Nordrheinwestfalen</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Bochum, Department of Dermatology</name>
      <address>
        <city>Bochum</city>
        <state>NRW</state>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HIV physician pratice</name>
      <address>
        <city>Duisburg</city>
        <state>NRW</state>
        <zip>47259</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Coordinating Center Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04107</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HIV Outpatient Department</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 21, 2019</study_first_submitted>
  <study_first_submitted_qc>November 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2019</study_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Essen</investigator_affiliation>
    <investigator_full_name>Stefan Esser M.D.</investigator_full_name>
    <investigator_title>PD Dr. med. Stefan Esser</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>AIDS</keyword>
  <keyword>Antiretroviral therapy</keyword>
  <keyword>Aging</keyword>
  <keyword>Heart failure</keyword>
  <keyword>coronary heart disease</keyword>
  <keyword>myocardial infarction</keyword>
  <keyword>HIV-associated neurocognitive disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>AIDS Dementia Complex</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

